Literature DB >> 12565992

Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.

S J Welsh1, S Hobbs, G W Aherne.   

Abstract

Uracil DNA glycosylase (UDG) is a base excision repair enzyme responsible for the removal of uracil present in DNA after cytosine deamination or misincorporation during replication. Inhibition of thymidylate synthase (TS), an important target for cancer chemotherapy, leads to deoxythymidine triphosphate (dTTP) pool depletion and elevation of deoxyuridine monophosphate (dUMP) pools which may also result in the accumulation of deoxyuridine triphosphate (dUTP). Large quantities of dUTP are believed to overwhelm the pyrophosphatase dUTPase, leading to misincorporation of uracil into DNA. Uracil is removed from DNA by uracil DNA glycosylase (UDG) resulting in an abasic site, but since the ratio dUTP:dTTP may remain high during continuing TS inhibition uracil can become re-incorporated into DNA causing a futile cycle eventually leading to DNA damage and cell death. This study has used isogenic cell lines differing in their expression of UDG to investigate the role of this enzyme in sensitivity to the specific TS inhibitors, ZD9331 and raltitrexed. The study showed that although increased expression and activity of UDG may lead to increased cell growth inhibition after TS inhibition over the first 24 h of treatment (measured using 3-(4,5-dimethyl (thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), probably due to increased damage to single-stranded DNA, the level of enzyme expression does not affect cell viability or cell death (measured using clonogenic assay, cell counting of attached/detached cells and cleavage of both poly ADP-ribose polymerase (PARP) and caspase 3). Increased expression and activity of UDG did not affect sensitivity to TS inhibition at later time points (up to 72 h treatment). Therefore UDG does not appear to play a major role in the response to TS inhibition, at least in the model used, and the results suggest that other determinants of response previously investigated, such as TS and dUTPase, may be more important for the response to TS inhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565992     DOI: 10.1016/s0959-8049(02)00610-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

Review 1.  Uracil in DNA: consequences for carcinogenesis and chemotherapy.

Authors:  Sondra H Berger; Douglas L Pittman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2008-07-01       Impact factor: 5.858

2.  5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway.

Authors:  Dipon Das; Ranjan Preet; Purusottam Mohapatra; Shakti Ranjan Satapathy; Sumit Siddharth; Tigist Tamir; Vaibhav Jain; Prasad V Bharatam; Michael D Wyatt; Chanakya Nath Kundu
Journal:  DNA Repair (Amst)       Date:  2014-12

3.  SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.

Authors:  Pratik Nagaria; David Svilar; Ashley R Brown; Xiao-Hong Wang; Robert W Sobol; Michael D Wyatt
Journal:  Mutat Res       Date:  2012-12-17       Impact factor: 2.433

4.  Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways.

Authors:  Soichiro S Ito; Yosuke Nakagawa; Masaya Matsubayashi; Yoshihiko M Sakaguchi; Shinko Kobashigawa; Takeshi K Matsui; Hitoki Nanaura; Mari Nakanishi; Fumika Kitayoshi; Sotaro Kikuchi; Atsuhisa Kajihara; Shigehiro Tamaki; Kazuma Sugie; Genro Kashino; Akihisa Takahashi; Masatoshi Hasegawa; Eiichiro Mori; Tadaaki Kirita
Journal:  J Biol Chem       Date:  2020-07-16       Impact factor: 5.157

5.  Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.

Authors:  Yuhong Luo; Mike Walla; Michael D Wyatt
Journal:  DNA Repair (Amst)       Date:  2007-10-17

6.  Induction of intrachromosomal homologous recombination in human cells by raltitrexed, an inhibitor of thymidylate synthase.

Authors:  Barbara Criscuolo Waldman; Yibin Wang; Kasturi Kilaru; Zhengguan Yang; Alaukik Bhasin; Michael D Wyatt; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2008-07-21

7.  DNA damage and homologous recombination signaling induced by thymidylate deprivation.

Authors:  Zhengguan Yang; Alan S Waldman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2008-08-19       Impact factor: 5.858

8.  Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination.

Authors:  Amelia M Huehls; Catherine J Huntoon; Poorval M Joshi; Carly A Baehr; Jill M Wagner; Xiaoxiao Wang; Marietta Y Lee; Larry M Karnitz
Journal:  Mol Pharmacol       Date:  2015-10-22       Impact factor: 4.436

9.  Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.

Authors:  Maria Wisniewska-Jarosinska; Tomasz Sliwinski; Jacek Kasznicki; Dariusz Kaczmarczyk; Renata Krupa; Karolina Bloch; Jozef Drzewoski; Jan Chojnacki; Janusz Blasiak; Alina Morawiec-Sztandera
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

10.  Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.

Authors:  Liyi Geng; Amelia M Huehls; Jill M Wagner; Catherine J Huntoon; Larry M Karnitz
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.